Genetic variants and clinical determinants affecting the response to 5-Fluorouracil-based treatment in Chilean patients with advanced colorectal cancer

BackgroundColorectal cancer is the second most prevalent cancer in Chile, affecting both sexes. Late-stage diagnosis occurs in approximately 25% of cases, with a five-year survival rate of only 14%. Standard treatment involves surgical resection followed by 5-fluorouracil-based chemotherapy, often c...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Leslie C. Cerpa, Christopher Sandoval, Paula Escalante, Juan P. Cayún, María A. Lavanderos, Claudio Alarcón-Concha, Guillermo Kaempfe, Diego Moreno-Tapia, Camilo S. Quiroz, Carolina Gutierrez-Cáceres, Olga Barajas, Bettina Müller, Alicia Colombo, Gerardo Donoso, Angie Nuñez, Nelson M. Varela, Luis A. Quiñones
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2025-07-01
Serie:	Frontiers in Oncology
Soggetti:	colorectal cancer 5-FU pharmacogenetics pharmacogenomics adverse drug reactions
Accesso online:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1589724/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!